The recent acquisition of Crinetics by Vertex Pharmaceuticals for $10 billion signals a strong trend in the healthcare sector towards consolidation and expansion. This theme focuses on companies involved in significant mergers and acquisitions in the healthcare space.
| Company | Price | Day Change % | Market Cap | Investment Profile | Market Cap |
|---|---|---|---|---|---|
| $263.04 | +3.57% | $492.44B | N/A | 492435825898$ | |
| $261.07 | +3.99% | $388.93B | N/A | 388929165998$ | |
| $374.15 | +3.55% | $174.46B | N/A | 174459660194$ | |
| $410.50 | +4.39% | $107.72B | N/A | 107723990519$ | |
| $786.30 | +2.37% | $102.01B | N/A | 102007495920$ | |
| $104.72 | -0.09% | $101.39B | N/A | 101389572577$ |
These stocks are filtered to include companies in the Healthcare sector with a market cap above $1B, focusing on those that have been involved in recent acquisitions or are likely to pursue growth through M&A.
Healthcare acquisitions involve one company purchasing another to expand its market presence, product offerings, or capabilities. This trend is common in the pharmaceutical and biotech industries.
Stocks are selected based on their classification in the Healthcare sector and a market cap exceeding $1 billion, with a focus on those that have announced or completed significant acquisitions.
The healthcare industry is witnessing a wave of consolidation as companies seek to enhance their portfolios and capabilities, particularly in areas like rare diseases and innovative treatments.
Investors should consider the integration risks associated with acquisitions, potential regulatory hurdles, and the financial impact of such transactions on the acquiring company.
Explore all 19 matching stocks
Filter, sort, and analyse with the full MarketCI screener — free to try.
Open Screener →